ULBI
UltralifeCAI scenario view
RankAlpha Sentiment CodexPost-earnings T+3The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
The post-print market reaction was positive: the latest finance quote showed $6.35, up $1.04, or approximately 19.5%, from the prior close. News tone is modestly positive because profitability and backlog improved, but revenue remained soft and the margin gain included a refund. Social coverage, options data, employee sentiment, and verified analyst revisions were unavailable; confidence therefore remains moderate rather than high.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
Q2 sales declined 1.3% year over year to $47.9 million, but GAAP EPS rose to $0.15 from $0.05, adjusted EBITDA rose to $6.1 million from $4.1 million, and backlog reached a record $117.5 million. Gross-margin improvement partly reflected a $1.1 million IEEPA refund and favorable mix. Management cited new products and defense programs as support for profitable 2026 growth. [#SEC-8K-2026-08-07] [#8-K-2026-08-07]
The next quarterly update should show whether manufacturing-efficiency gains persist after the IEEPA refund and favorable mix benefit, while higher product-development spending and one-time costs remain execution considerations. [#SEC-8K-2026-08-07]
Management said Communications Systems products are moving through capture, multiple government/defense products are planned for launch later in 2026, and several Battery & Energy Programs may transition into production later this year. Conversion timing remains unquantified. [#SEC-8K-2026-08-07]
Recommendation
No formal recommendation provided.

